Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
editas medicine
4
×
life sciences
national blog main
national top stories
4
×
biotech
crispr
crispr-cas9
san francisco blog main
san francisco top stories
boston
broad institute
cancer
crispr therapeutics
david liu
gene editing
intellia therapeutics
national
new york blog main
advaxis
agios therapeutics
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
andrew oxtoby
babies
base editing
beam therapeutics
biotech week boston
boulder/denver blog main
boulder/denver top stories
branden moriarty
breakup
bridge bio pharma
bristol-myers squibb
bwb
cas13
ceo
cindy perettie
What
medicine
4
×
cas
crispr
editas
editing
gene
beam
benefiting
big
bio
bosley's
bosley’s
boston
bridge
bucks
cancer
cells
ceo
coming
crime
defect
departure
diagnostics
drive
edited
editor
exit
fears
flag
founders
genetic
glimcher
gotten
groundbreaking
guardian
guiding
harvard
headline
human
jump
Language
Current search:
medicine
×
" national top stories "
×
" editas medicine "
×
@xconomy.com
5 years ago
Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
@xconomy.com
6 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M